Skip to content

Cumberland Pharmaceuticals CPIX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Baxter International logo
Baxter InternationalBAX
$277M-8.0%
PTH
Pelthos Therapeutics Inc.PTHS
8.4%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$785K-39.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$17.23M+140%
Opko Health logo
Opko HealthOPK
$45.8M-4.2%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
7.5%0.0pp

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+142%
Enterprise value$90.91M+212%
P/S2.3×+1.4×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's operating lease ROU assets?
Cumberland Pharmaceuticals (CPIX) reported operating lease ROU assets of 9.4% in Q1 2026.
How has Cumberland Pharmaceuticals's operating lease ROU assets changed year-over-year?
Cumberland Pharmaceuticals's operating lease ROU assets decreased by 0.2% year-over-year, from 9.4% to 9.4%.
What is the long-term trend for Cumberland Pharmaceuticals's operating lease ROU assets?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's operating lease ROU assets has grown at a -96.6% compound annual growth rate (CAGR), from 202,814,800% to 9.4%.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.